[8-K] Cadrenal Therapeutics, Inc. Reports Material Event

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Analyzing...

07/18/2025 - 04:49 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Cadrenal Therape

#8010 Ranked by Market Cap

N/A Ranked by Dividends

Jun 12, 2025

Jun 4, 2025

May 15, 2025

May 8, 2025

Apr 17, 2025

Market Cap 25.57M

Float 1.39M

Insiders Ownership 30.69%

Institutions Ownership 5.65%

Short Percent 1.65%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City PONTE VEDRA